Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
about
Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in KoreaCancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.Malignancy in systemic lupus erythematosus: what have we learned?A review of the application of inflammatory biomarkers in epidemiologic cancer research.Thyroid cancer in systemic lupus erythematosus: a meta analysisNew classification criteria for systemic lupus erythematosus correlate with disease activityMultiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancerBreast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.Incidence of neoplasms in the most prevalent autoimmune rheumatic diseases: a systematic review.Prostate cancer in systemic lupus erythematosusSystemic lupus erythematous and malignancy risk: a meta-analysis.Characteristics and prognosis of colorectal cancer associated with rheumatic disease.Mixed Connective Tissue Disease and Papillary Thyroid Cancer: A Case Report.Functional Module Analysis for Gene Coexpression Networks with Network Integration.Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population.Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients.AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4Malignancies in systemic lupus erythematosusSystemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review.Malignancy as a comorbidity in rheumatic diseases.Immunosuppression and risk of cervical cancer.What is the background incidence of malignancy in children with rheumatic disease?Immunomodulation and lymphoma in humans.Bioreactivity of the crystalline silica polymorphs, quartz and cristobalite, and implications for occupational exposure limits (OELs).Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women.Cervical neoplasia in systemic lupus erythematosus: a nationwide study.Breast cancer in systemic lupus.Systemic lupus erythematosus and malignancies risk.Dialogue: what can we learn about the relationship between systemic lupus erythematosus and haematological malignancies from linking disease registries?The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answersLong-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues.High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.Thyroid nodules in Hispanic patients with systemic lupus erythematosus.The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
P2860
Q26739361-F23969CF-D5A9-4478-BBF7-347503123F58Q30580226-A68A4FB3-84B4-4B9C-83D3-9EBC74EE7C44Q33842149-0C80FA0B-1B0D-4564-8BF9-EF0E655AA0C4Q33937936-D096948E-6454-46CA-941D-A3177E03EB54Q34087859-840C3F1F-6F74-4877-A8C4-9C314C799CC2Q34135803-1784CF00-E0F9-44EB-852B-91B7D4DCC446Q34371770-61E5F0B3-C2C3-458F-A205-029F7D1B66A4Q34492782-EE2640BD-C150-4BC2-908C-F3D7593E3BB2Q34637366-C35D4A72-EB1F-4ABF-96B5-3B67956D1194Q35006892-059F4E89-6978-4ACF-A847-DD421FA9E724Q35176767-6E37F2A5-6A5A-4807-A14D-F4C428D96527Q35464068-34C060D4-2C70-4139-A611-C5F8D392C1C7Q35464796-1A0665EB-F243-4ED6-AB2C-5989789CD73DQ35676140-7172D6CE-D107-41CB-9347-459A3D33E899Q35934776-89D8C617-3006-4A33-BBD4-AD38D14154B8Q36331261-9175FE44-9882-4BFE-8BB8-431E09577FB3Q36416287-98E359C2-1590-4164-9E79-524B42B1B3CFQ36773349-22D9EA2B-6ECF-423B-BBD3-148963675B24Q37007011-70CDC402-5B4A-4EBE-B1D7-5B97477D9FC7Q37146254-DACF5C20-3A2F-48BA-9F37-C4B2D478C6D7Q37433350-E2A12EF3-EA1B-4AB4-88E7-B8196260661CQ37808965-4B62C24E-EC9C-499E-8F74-4A3DBA6A64B1Q38029322-83B0A8FF-FB41-4E3E-A797-0D89917C2F58Q38069182-FB2B4128-84A2-43C1-9BD4-389A97EA1882Q38078882-B9A1E0CC-0F9A-49D0-AB20-C9EF2FD9C626Q38112841-D5A61B13-C9A7-497A-8EDE-29E613DBF95BQ38122211-6F97BDB2-802D-431D-BED7-AF3A5AE0ABD1Q38178804-D1E52A71-2EA7-4CDD-AB46-2FCCD5CEA116Q38187858-E83B7B19-B3C4-4D29-B631-CA8DF5DCC194Q40383158-C52BCA00-D237-4E7C-A1AF-F25457947B79Q40401221-6459EB46-A5A3-496D-ABB3-B49C2C6E651DQ40559886-DE868A84-71D2-42AB-8E62-DF7CC122D1C0Q41441163-49C1BF92-94CA-4020-8BAA-EB653686A771Q41976089-F865B0D5-9B47-4F4C-8A3A-4CCA83A6E862Q42325041-E8927845-F415-4EB5-BB32-2DDAFCE4C7EBQ42652135-7EB2F87E-F7A2-4309-B5BF-5E715F6E5FE4Q44212883-A63E25F9-EB77-4B7A-B7EC-201BCB94979AQ45362963-98921F27-A865-4BB7-A118-4CF994FB964DQ46164059-5BBE6204-5D4B-4EC0-83ED-F92845E454A5Q50932896-3E0B3B6A-E2A9-41C2-9ACC-99BEA11C7AA3
P2860
Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cancer risk in a cohort of pat ...... hematosus (SLE) in California.
@ast
Cancer risk in a cohort of pat ...... hematosus (SLE) in California.
@en
type
label
Cancer risk in a cohort of pat ...... hematosus (SLE) in California.
@ast
Cancer risk in a cohort of pat ...... hematosus (SLE) in California.
@en
prefLabel
Cancer risk in a cohort of pat ...... hematosus (SLE) in California.
@ast
Cancer risk in a cohort of pat ...... hematosus (SLE) in California.
@en
P2093
P2860
P1476
Cancer risk in a cohort of pat ...... hematosus (SLE) in California.
@en
P2093
Arti Parikh-Patel
Mark Allen
Richard H White
Rosemary Cress
P2860
P2888
P304
P356
10.1007/S10552-008-9151-8
P577
2008-04-02T00:00:00Z